Key result
ATP addition to sarcoplasmic reticulum vesicles in the presence of lasalocid revealed a biphasic tryptophan fluorescence drop corresponding to the formation and transition of the phosphoenzyme intermediate.
The study reveals the conditions that discriminate the two phases of tryptophan fluorescence drop during the conformational transition of the phosphoenzyme intermediate in sarcoplasmic reticulum Ca2+-ATPase.
No direct clinical implications; leaves open mechanistic details of SERCA phosphoenzyme transitions for further study.
ATP-induced changes in the tryptophan fluorescence of the Ca(2+)-ATPase were determined with sarcoplasmic reticulum vesicles at pH 7.0 and 0 degrees C by steady-state measurements in the presence of Ca2+ and the absence of K+ with and without added lasalocid (a carboxylic ionophore, 50 microM), which was previously shown to cause a predominant accumulation of the ADP-insensitive form of the phosphoenzyme intermediate (EP) (Kawashima, T., Hara, H., and Kanazawa, T. (1990) J. Biol. Chem. 265, 10993-10999). When ATP was added in the absence of lasalocid, the fluorescence decreased by 1.7%. The addition of lasalocid quenched 71% of the fluorescence but did not reduce the ATP-induced fluorescence drop. The fluorescence drop and the EP formation were also determined in the presence of lasalocid by stopped-flow spectrometry and continuous-flow rapid quenching. The observed fluorescence drop was biphasic. The first phase coincided with the formation of EP, which was largely ADP-sensitive in this early stage of the reaction. The second phase was much slower than the first phase and coincided with the accumulation of ADP-insensitive EP. When the transition of EP from the ADP-sensitive form to the ADP-insensitive form was blocked by N-ethylmaleimide treatment, the second phase disappeared, and the fluorescence drop entirely coincided with the formation of ADP-sensitive EP. These findings demonstrate that the first phase of the fluorescence drop is attributed to the formation of ADP-sensitive EP, the second phase being attributed to the transition of EP from the ADP-sensitive form to the ADP-insensitive form. The present results reveal the conditions that definitely discriminate these two phases.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1995) studied this question. ATP addition with lasalocid vs. Absence of lasalocid was evaluated on Tryptophan fluorescence change and phosphoenzyme intermediate (EP) formation. ATP addition to sarcoplasmic reticulum vesicles in the presence of lasalocid revealed a biphasic tryptophan fluorescence drop corresponding to the formation and transition of the phosphoenzyme intermediate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: